Jazz Pharmaceuticals
JAZZ
$107.10
Share price
-1.65%
Change (1 day)
-26.61%
Change (1 year)
Categories
Market capitalization of Jazz Pharmaceuticals (JAZZ)
Market cap: $6.67 Billion
As of April 2024 Jazz Pharmaceuticals has a market cap of $6.67 Billion. This makes Jazz Pharmaceuticals the world's 2144th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Jazz Pharmaceuticals from 2007 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $6.67 B | -13.77% |
| 2023 | $7.74 B | -22.8% |
| 2022 | $10.03 B | 28.09% |
| 2021 | $7.83 B | -15.53% |
| 2020 | $9.27 B | 10.63% |
| 2019 | $8.38 B | 17.57% |
| 2018 | $7.12 B | -11.7% |
| 2017 | $8.07 B | 23.62% |
| 2016 | $6.53 B | -24.22% |
| 2015 | $8.61 B | -13.21% |
| 2014 | $9.92 B | 35.61% |
| 2013 | $7.32 B | 137.02% |
| 2012 | $3.08 B | 89.69% |
| 2011 | $1.62 B | 107.09% |
| 2010 | $0.78 B | 219.3% |
| 2009 | $0.24 B | 419.79% |
| 2008 | $47.38 M | -86.87% |
| 2007 | $0.36 B |
End of Day market cap according to different sources
On Apr 17th, 2024 the market cap of Jazz Pharmaceuticals was reported to be:
$6.67 Billion
$6.67 Billion
$6.67 Billion
$6.75 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $190.25 B | 2,749.38% | 🇨🇭 Switzerland |
 AmerisourceBergen
ABC | $36.14 B | 441.39% | 🇺🇸 USA |
 Endo International
ENDPQ | $0.14 M | -100.00% | 🇮🇪 Ireland |
 Teva Pharmaceutical Industries TEVA | $14.92 B | 123.57% | 🇮🇱 Israel |